Community‐associated methicillin‐resistant Staphylococcus aureus and impetigo
暂无分享,去创建一个
[1] Y. Yang,et al. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community‐associated methicillin‐resistant Staphylococcus aureus to be uncommon and heterogeneous , 2009, The British journal of dermatology.
[2] F. Vandenesch,et al. Global Distribution of Panton-Valentine Leukocidin–positive Methicillin-resistant Staphylococcus aureus, 2006 , 2007, Emerging infectious diseases.
[3] Roberta B Carey,et al. Methicillin-resistant S. aureus infections among patients in the emergency department. , 2006, The New England journal of medicine.
[4] S. Ray,et al. Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Clone as the Predominant Cause of Skin and Soft-Tissue Infections , 2006, Annals of Internal Medicine.
[5] F. Vandenesch,et al. Emergence of two populations of methicillin‐resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community‐acquired skin infections , 2006, The British journal of dermatology.
[6] R. Auckenthaler,et al. Community-Acquired Methicillin-Resistant Staphylococcus aureus Isolated in Switzerland Contains the Panton-Valentine Leukocidin or Exfoliative Toxin Genes , 2004, Journal of Clinical Microbiology.
[7] M. Aepfelbacher,et al. Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan. , 2002, The Journal of infectious diseases.
[8] P. Couppié,et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. , 1995, Journal of medical microbiology.
[9] P. Couppié,et al. Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. , 1994, Archives of dermatology.